FDA Inspection 1256957 — Exela Pharma Sciences LLC

Exela Pharma Sciences LLC — FEI 3008563008

The FDA completed an inspection of Exela Pharma Sciences LLC on November 15, 2024 in Lenoir, NC. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 15, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lenoir, NC (United States)